Changes to documentation requirements for Authorised Prescriber applications The TGA on 5th July 2021 advised that they will accept endorsement for Authorised Prescriber applications for unapproved products for a duration of up to 5 years, and endorsement for...
TGA confirms new Schedule 3 entry for CBD The Therapeutic Goods Administration issued on 15th Dec 2020 its final decision on proposed amendments to the Poison Standard which, amongst other amendments, sees a new Schedule 3 entry created for cannabidiol. The date of...
The history of cannabis and its usage by humans dates back to at least the third millennium BCE in written history, and possibly further back by archaeological evidence. For millennia (as early as 800 BC in Japan), the plant has been valued for its use for fiber and...
Cannabidiol (CBD) is a natural medicine extracted from the cannabis plant, used to potentially treat or alleviate symptoms of many illnesses. As one of 100+ chemical compounds found in the cannabis plant (known as cannabinoids), CBD is well-known for its potential...